Russell Investments Group, Ltd. - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 235 filers reported holding FATE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.

Quarter-by-quarter ownership
Russell Investments Group, Ltd. ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$369,899
-58.5%
174,481
-6.9%
0.00%
-50.0%
Q2 2023$892,383
-9.0%
187,476
+8.9%
0.00%0.0%
Q1 2023$980,911
+18279.4%
172,090
+32431.2%
0.00%
Q4 2022$5,337
-51.5%
5290.0%0.00%
Q3 2022$11,000
-15.4%
5290.0%0.00%
Q2 2022$13,000
-35.0%
5290.0%0.00%
Q1 2022$20,000
-33.3%
5290.0%0.00%
Q4 2021$30,000
-3.2%
5290.0%0.00%
Q3 2021$31,000
-92.7%
529
-89.3%
0.00%
-100.0%
Q2 2021$427,000
-86.6%
4,924
-87.3%
0.00%
-83.3%
Q1 2021$3,192,000
-41.2%
38,736
-35.1%
0.01%
-45.5%
Q4 2020$5,426,000
+99.0%
59,648
-12.6%
0.01%
+83.3%
Q3 2020$2,726,000
+16.6%
68,2510.0%0.01%
+20.0%
Q2 2020$2,338,000
+6.2%
68,251
-31.1%
0.01%
-16.7%
Q1 2020$2,201,000
-28.5%
99,078
-37.0%
0.01%0.0%
Q4 2019$3,078,000
+118.6%
157,358
+73.5%
0.01%
+100.0%
Q3 2019$1,408,000
+501.7%
90,677
+53.3%
0.00%
Q3 2017$234,00059,1680.00%
Other shareholders
FATE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 3,379,064$131,006,00024.77%
Redmile Group, LLC 12,957,222$502,351,00015.68%
Grosvenor Holdings, L.L.C. 1,037,256$40,214,0007.85%
Casdin Capital, LLC 3,400,000$131,818,0005.91%
Ally Bridge Group (NY) LLC 181,500$7,037,0005.22%
DAFNA Capital Management LLC 500,930$19,421,0005.06%
Deep Track Capital, LP 2,000,000$77,540,0004.97%
Artal Group S.A. 2,000,000$77,540,0003.25%
Tri Locum Partners LP 190,345$7,380,0002.88%
ARK Investment Management 10,988,182$426,012,0001.78%
View complete list of FATE THERAPEUTICS INC shareholders